Tesla’s Samsung order shift unlikely to hurt TSMC: Morgan Stanley
ROCHESTER, NY – Paychex Inc . (NASDAQ:PAYX), a leading provider of integrated human capital management solutions for payroll, benefits, human resources, and insurance services, boasts a robust market capitalization of $50.6 billion and impressive gross profit margins of 72%. According to InvestingPro analysis, the company maintains a GREAT financial health score and has consistently raised its dividend for 11 consecutive years, though recent market activity shows a 9% decline over the past week. [Discover 12 more exclusive InvestingPro Tips and comprehensive analysis in our detailed Pro Research Report, available with an InvestingPro subscription.]
In other recent news, Paychex has reported its third-quarter earnings for fiscal year 2025, slightly surpassing analysts' expectations with an earnings per share (EPS) of $1.49, compared to the forecast of $1.48. Revenue met predictions at $1.51 billion, marking a 5% increase from the previous year. RBC Capital Markets maintained its Sector Perform rating for Paychex, with a price target of $148, citing stable demand and improvements in margins. Meanwhile, Stifel raised its price target for Paychex from $141 to $156, acknowledging the company's strong third-quarter results, including a 6% revenue increase and an 8% rise in EPS. Citi also adjusted its price target for Paychex to $158 from $145, noting robust client retention and positive growth in bookings. The anticipated acquisition of Paycor (NASDAQ:PYCR) is expected to drive a 10-12% revenue increase in the fourth quarter, as Paychex continues to invest in technology-driven solutions. TD Cowen maintained its Hold rating with a $147 price target, emphasizing Paychex's strong operational performance despite macroeconomic challenges. These developments highlight Paychex's strategic maneuvers and financial resilience in the current economic landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.